{"id":1095,"date":"2013-04-01T11:15:33","date_gmt":"2013-04-01T11:15:33","guid":{"rendered":"\/?p=1095"},"modified":"2013-04-01T11:21:54","modified_gmt":"2013-04-01T11:21:54","slug":"ap-pharma-inc-otcappa-threatens-with-deeper-falls","status":"publish","type":"post","link":"\/articles\/ap-pharma-inc-otcappa-threatens-with-deeper-falls\/","title":{"rendered":"AP Pharma, Inc. (OTC:APPA) Threatens with Deeper Falls"},"content":{"rendered":"<p> The new trading week will start on a bad note for AP Pharma, Inc. (OTC:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a>) as it received depressing news from the FDA. Late on Thursday the stock ran down more than 36% to 37 cents per share and more than 40 million shares were shed. In the past months, the <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a> ticker was supported by expectations of a favorable FDA ruling, and a second refusal for the company&#8217;s anti-nausea therapy cut down the trend even more. <img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"http:\/\/www.hotstocked.com\/articles-img\/small\/APPA0401.png\" border=\"0\" alt=\"APPA0401.png\" title=\"APPA0401.png\" width=\"400\" height=\"178\" \/> <\/p>\n<p>So far, the underlying business of <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a> has shown most of the marks of a pharmaceutical developer that has a long way to go before it hits marketing success. The financials show a mix of debt burden and accumulated losses: <img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"http:\/\/www.hotstocked.com\/articles-img\/small\/TTNP0410.png\" border=\"0\" alt=\"TTNP0410.png\" title=\"TTNP0410.png\" width=\"350\" height=\"156\" \/><\/p>\n<ul>\n<li>$53,506,000 cash <\/li>\n<\/ul>\n<ul>\n<li>$55,172,000 total assets <\/li>\n<\/ul>\n<ul>\n<li>$4.1 million liabilities <\/li>\n<\/ul>\n<ul>\n<li>Zero revenues <\/li>\n<\/ul>\n<ul>\n<li>$23 million net annual loss for 2012 <\/li>\n<\/ul>\n<p>On the positive side, the refusal is still not final and might just put off the release of the APF530 drug by about a year. This may cause renewed interest among investors, and a new strong period for the stock. In the past, long periods without the promise of a recent release have depressed the stock to nearly 10 cents, from highs of $1 to $1.10.<\/p>\n<p>Adding to the activity is a promotional email from March 13th that may have attracted more investors than usual to <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a>, and as a side effect deepened the fall. The promotion from NYC Marketing is without compensation, probably an attempt to boost the pumper&#8217;s past record. The promotion of <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a> brings another level of caution to this stock.<\/p>\n<p>A similar development touched Titan Pharmaceuticals, Inc. (OTC:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TTNP\">TTNP<\/a>) last week, when a statement from the FDA decreased hopes for the company&#8217;s newest therapy proposal. Fueled by hope, investors shed their holdings at the first sight of negative news, wiping out almost half the stock&#8217;s value. <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TTNP\">TTNP<\/a> has since then started a slow and shaky recovery, and awaits April 30th when a final verdict from the FDA is expected.<\/p>\n<p>In the past weeks, both <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a> and <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TTNP\">TTNP<\/a> showed amazing trends on promises of a drug release in the near future. They were part of a general rising direction among small cap biopharmaceutical companies. But the key to these and other tickers is to know their disproportionate rise is a thing of irrational optimism and expectations, which may deflate at any moment. Keep this in mind and mark your acceptable losses and your preferable time period, because <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=APPA\">APPA<\/a> and <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TTNP\">TTNP<\/a> may be in the mood for a downward shift even if you are not.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The new trading week will start on a bad note for AP Pharma, Inc. (OTC:APPA) as it received depressing news from the FDA. Late on Thursday the stock ran down more than 36% to&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[41,11],"class_list":["post-1095","post","type-post","status-publish","format-standard","hentry","category-news","tag-appa","tag-ttnp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/1095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=1095"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/1095\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=1095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=1095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=1095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}